Abiopharma

🔍 Grotke Kevin Allan (Executive)

Company: Capstone Holding Corp. (CAPS)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 515,495 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,041,597.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 515,495 shares of common stock granted to the Reporting Person on August 7, 2026 as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full on August 7, 2029, the third anniversary of the grant date, subject to the Reporting Person's continued service.